Haemonetics Corp. (HAE) announced on Sunday that it entered into a definitive agreement to acquire the business assets of the blood collection, filtration and processing product lines of Pall Corp. (PLL).
Haemonetics also reported fourth quarter non-GAAP net income of $0.80 per share, down from $0.85 per share in the prior year. The consensus estimate was for EPS of $0.83. Full year 2013 adjusted EPS is expected to be between $3.30 and $3.40, compared to the consensus estimate of $3.50.
Haemonetics spiked to the upside at the open Monday, before settling into a range. The stock ended the day higher by 2.86 at $71.57, with volume at a 3-month high. Haemonetics climbed past resistance and set a new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.